Strategic Initiative

Slingshot members are tracking this corporate initiative:

Bristol-Myers Squibb (BMY) Announces Collaboration Agreement with Enterome to Develop Microbiome-Derived Biomarkers for Cancer

Source Link:
http://investor.bms.com/investors/news-and-events/press-releases/press-release-details/2016/Bristol-Myers-Squibb-and-Enterome-Announce-Immuno-Oncology-Collaboration-Focused-on-Microbiome-Derived-Biomarkers-Drug-Targets-and-Bioactive-Molecules/default.aspx

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
BMY
100%
Enterome
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Strategic Initiative Date
Announcement Date:
Nov 16, 2016
Projected Implementation:
Q1, 2017
Relevance Tracked Until:
Q1, 2019
Related Projects Image

  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Collaboration Agreement, Microbiome-derived, Biomarkers, Drug Targets, Bioactive Molecules
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.